Advate 1 UNT Injection

RxCUI
1719225
RxNorm name
Advate 1 UNT Injection
Display name
Advate 1 UNT Injection
Full name
Advate 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125063AdvateAntihemophilic Factor (Recombinant), Plasma/Albumin Free Method351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADVATEANTIHEMOPHILIC FACTOR (RECOMBINANT)Takeda Pharmaceuticals America, Inc.80fa03d2-cd4c-4155-9b57-1396c4fa42da2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 1719225

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
80fa03d2-cd4c-4155-9b57-1396c4fa42daAdvate 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [Advate] [SBD] · Advate 1 UNT Injection [SY]313These highlights do not include all the information needed to use ADVATE ® safely and effectively. See full prescribing information for ADVATE. ADVATE [antihemophilic factor (recombinant)] lyophilized powder for reconstitution, for intravenous injection Initial U.S. Approval: 200320250403